Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Quehenberger

Showing results (111-120 of 134) with videos related to

Pageof 14
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 16, 2022
The Sequential Application of Baveno VII Criteria and VITRO Score Improves Diagnosis of Clinically Significant Portal HypertensionMathias Jachs, Lukas Hartl, Benedikt Simbrunner, et al.
Haematologica|November 25, 2021
The von Willebrand factor A-1 domain binding aptamer BT200 elevates plasma levels of von Willebrand factor and factor VIII: a first-in-human trialKatarina D Kovacevic, Jürgen Grafeneder, Christian Schörgenhofer, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 2, 2016
von Willebrand factor antigen (vWF-Ag): A non-invasive predictor of treatment response and serious adverse events in HCV patients with interferon triple therapyKaroline Rutter, Alexandra Etschmaier, Monika Ferlitsch, et al.
Wiener Klinische Wochenschrift|August 21, 2014
Dabigatran: patient management in specific clinical settingsPaul Alexander Kyrle, Konrad Binder, Sabine Eichinger, et al.
JHEP Reports : Innovation in Hepatology|December 11, 2023
Platelet adhesion assessed by PFA-100 is not linked to progression of ACLDLorenz Balcar, Benedikt Simbrunner, Rafael Paternostro, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 21, 2021
Safety of direct oral anticoagulants in patients with advanced liver diseaseGeorg Semmler, Katharina Pomej, David J M Bauer, et al.
Hepatology International|August 21, 2023
Von Willebrand factor processing in patients with advanced chronic liver disease and its relation to portal hypertension and clinical outcomeBenedikt Simbrunner, Ida Falk Villesen, Bernhard Scheiner, et al.
Thrombosis Research|February 1, 2012
Continuous thrombin infusion leads to a bleeding phenotype in sheepJolanta M Siller-Matula, Ingrid Miller, Manfred Gemeiner, et al.
Hepatology International|December 8, 2020
Vitamin A levels reflect disease severity and portal hypertension in patients with cirrhosisBenedikt Simbrunner, Georg Semmler, Alexander Stadlmann, et al.
Journal of Thrombosis and Haemostasis : JTH|January 11, 2025
Accurate evaluation of factor VIII activity of efanesoctocog alfa in the presence of emicizumabChristophe Nougier, Steven W Pipe, Ingrid Pabinger, et al.
Pageof 14

Showing results (111-120 of 134) with videos related to

Sort By:
Pageof 14
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 16, 2022
The Sequential Application of Baveno VII Criteria and VITRO Score Improves Diagnosis of Clinically Significant Portal HypertensionMathias Jachs, Lukas Hartl, Benedikt Simbrunner, et al.
Haematologica|November 25, 2021
The von Willebrand factor A-1 domain binding aptamer BT200 elevates plasma levels of von Willebrand factor and factor VIII: a first-in-human trialKatarina D Kovacevic, Jürgen Grafeneder, Christian Schörgenhofer, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 2, 2016
von Willebrand factor antigen (vWF-Ag): A non-invasive predictor of treatment response and serious adverse events in HCV patients with interferon triple therapyKaroline Rutter, Alexandra Etschmaier, Monika Ferlitsch, et al.
Wiener Klinische Wochenschrift|August 21, 2014
Dabigatran: patient management in specific clinical settingsPaul Alexander Kyrle, Konrad Binder, Sabine Eichinger, et al.
JHEP Reports : Innovation in Hepatology|December 11, 2023
Platelet adhesion assessed by PFA-100 is not linked to progression of ACLDLorenz Balcar, Benedikt Simbrunner, Rafael Paternostro, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 21, 2021
Safety of direct oral anticoagulants in patients with advanced liver diseaseGeorg Semmler, Katharina Pomej, David J M Bauer, et al.
Hepatology International|August 21, 2023
Von Willebrand factor processing in patients with advanced chronic liver disease and its relation to portal hypertension and clinical outcomeBenedikt Simbrunner, Ida Falk Villesen, Bernhard Scheiner, et al.
Thrombosis Research|February 1, 2012
Continuous thrombin infusion leads to a bleeding phenotype in sheepJolanta M Siller-Matula, Ingrid Miller, Manfred Gemeiner, et al.
Hepatology International|December 8, 2020
Vitamin A levels reflect disease severity and portal hypertension in patients with cirrhosisBenedikt Simbrunner, Georg Semmler, Alexander Stadlmann, et al.
Journal of Thrombosis and Haemostasis : JTH|January 11, 2025
Accurate evaluation of factor VIII activity of efanesoctocog alfa in the presence of emicizumabChristophe Nougier, Steven W Pipe, Ingrid Pabinger, et al.
Pageof 14